Effects of short term metformin administration on androgens in normal men

Saudi Medical Journal

Volumn 23, Issue 8, 2002, Pages 934-937

  Shegem, Nadima S ^a   Nasir, Abeer M ^a   Jbour, Abdel Kareem ^a   Batieha, Anwar M ^b   El Khateeb, Moh'd S ^a   Ajlouni, Kamel M ^a  

^a National Center for Diabetes Endocrinology and Genetics Jordan   (Jordan)

^b JORDAN UNIVERSITY HOSPITAL   (Jordan)

Author keywords

Androgen; Changes; Men; Metformin; Normal

Indexed keywords

ANDROGEN; FOLLITROPIN; GLUCOSE; HYDROXYPROGESTERONE; INSULIN; LUTEINIZING HORMONE; METFORMIN; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; FOLLITROPIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MALE; NORMAL HUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TESTOSTERONE BLOOD LEVEL; VOLUNTEER;

ADULT; ANDROGENS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; REFERENCE VALUES;

EID: 0036700491     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Cusi K, DeFronzo R. Metformin: A review of its metabolic effects. Diabetic Review 1998; 6: 89-131.
2. Dorrella M, Guisto M, Tos V, Campagnolo M, Platini P, Rossi G et al. Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance. J Clin Endocrinol Metab 1996; 81: 1568-1574.
3. UK Prospective Diabetic Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-865.
4. DeFronzo RA, Barzilai N, Simonsone DC. Mechanism of metformin action in obese and lean noninsulin-dependant diabetic subjects. J Clin Endocrinol Metab 1991; 73: 1294-1301.
5. Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependant diabetes mellitus. J Clin Endocrinol Metab 1996; 81: 4059-4067.
6. Velazquez EM, Mendoza S, Hamer T, Sosa F, Glueck CJ. Metformin therapy in polycystic ovary syndrom reduces hyperinsulinemia, insulin resistance, hyperandregenaemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 1994; 43: 647-654.
7. De Leo V, La Marca A, Orvieto R, Morgante G. Effect of metformin on insulin- like growth factor (IGF) 1 and IGF-Binding protien 1 in polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 1598-1600.
8. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D et al. Effect of long term treatment with meformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85: 2767-2774.
9. Nestler JE, Jakubawicz DJ. Decrease in ovarian cytochrome P450c17 activity and serum free testosterone after reduction in insuliin secretion in women with polycystic ovary syndrome. N Engl J Med 1996; 335: 617-623.
10. Nestler JE, Jakubawicz DJ. Lean women with polycystic ovary syndrome respond to insulin reduction with decrease in ovarian P450c17 activity and serum androgens. J Clin Endocrinol Metab 1997; 82: 4075-4079.
11. Velazquez EM, Acosta A, Mendosa S. Menstrual cyclicity after metformin metformin therapy in polycystic ovary syndrom. Obstet Gynocol 1997; 90: 392-395.
12. Crave J, Fimbel S, Lejeune H, Cugnardey N, Dechaud H, Pugeat M. Effects of Diet and Metformin Administration on Sex Hormone-Binding Globulin, Androgens, and Insulin in Hirsute and Obese Women. J Clin Endocrinol Metab 1995; 80: 2057-2062.
13. Nestler J. Editorial. Sex Hormone Binding Globulin: a marker for Hyperinsulinaemia and/or or Insulin Resistance? J Clin Endocrinol 1993; 76: 273-274.
14. Bailey GJ. Biguanides and NIDDM. Diabetes Care 1992; 15: 755-772.
15. Peiris AN, Stagner JI, Plymate SR, Vogel RL, Heck M, Samols E. Relation of insulin secretory pulses to sex hormone-binding globulin in normal men. J Clin Endocrinol Metab 1993; 76: 279-282.
16. Birkeland KI, Hanssen KF, Torjesen PA, Vaaler S. Level Of Sex Hormone-Binding Globulin Is Positivly Correlated With Insulin Sensitivity In Men with Type 2 DM. J Clin Endocrinol Metab 1993; 76: 277-279.
17. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K et al. Interrelation between Plasma Sex Hormone-Binding Globulin and Plasma Insulin in Healthy Adult Women: The Telecom Study. J Clin Endocrinol Metab 1993; 76: 283-287.
18. Moghetti P, Castello C, Negri C, Tosi F, Perrone F, Caputo M et al. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metab 2000; 85: 2767-2777.
19. Marfella R, Acampora R, Verrazzo G, Ziccardi P, Nicoleta De Rosa N, Giunta R et al. Metformin improves hemodynamic and rheological responses to L-arginine in NIDDM patients. Diabetes Care 1996; 19: 934-939.
20. Ehrmann DA, Cavaghan MK, Imperial J, Struris J, Rosenfield RL, Polonsky KS et al. Effects of metformin on insulin secretion, insulin action, and ovarian steroidogenesis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997; 82: 524-530.
21. Jansson PE, GudbjÖrndottir HS, Anderssone OK, Ionnroth PN. The effect of metfomin on adipose tissue metabolism and periphoral blood flow in subjects with NIDDM. Diabetes Care 1996; 19: 160-164.
22. Legro RS, Finegood D, Dunaif A. Fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1998; 83: 2694-2698.
23. Mathews DR, Hosker JP. Homoestasis model assessment: insulin resistance and β-cell function from plasma glucose and insulin concentration in man. Diabetologia 1985; 28; 412-419.
24. Gonzalez-Albarran O, Garcia-Robles R. Correlation between insulin suppression test and quantitative insulin sensitivity check index in hypertensive and normotensive obese patients. Diabetic Care 2001; 24: 1998-1999.
25. Pratly RE, Weyer C. The role of impaired early insulin secretion in the pathogenesis of type 11 diabetes mellitus. Diabetologia 2001; 44: 929-945.
26. Nestler JE, Usiskin KS, Barlascini CO, Welty DF, Clore JN, Blackard WG. Suppression of serum dehydroepiandrosterone sulfate level by insulin: An evaluation of possible mechanisms. J Clinical Endocrinol Metab 1989; 69: 1040-1046.
27. Nestler JE, Beer NA, Jakubowicz DJ, Beer RM. Effect of reduction in circulating insulin by metformin on serum Dehydroepiandrsterone sulfate in nondiabetic men. J Clin Endocrinol Metab 1994; 78: 549-554.
28. Nestler JE, McClanahan MA, Clore JN, Blackard W. Insulin inhibits adrenal 17, 20-lyase activity in man. J Clin Endocrinol Metab 1992; 74: 362-367.
29. La Marca A, Morgante G, Paglia T, Ciotta L, Cianci A, De Leo V. Effects of metformin on adrenal stereoidogenesis in women with polycystic ovary syndrome. Fertil Steril 1999; 72: 985-989.